LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition, announced today it has been informed by the U.S. Food and Drug Administration that the company’s pharmaceutical manufacturing facility in Grand Island, N.Y., has achieved the upgraded status of voluntary action indicated (VAI) following an October 2014 inspection. The status change is an improvement from the “official action indicated” status the facility had been operating under.
Help employers find you! Check out all the jobs and post your resume.
